Table 3 Molecular markers and haplotype prevalence
Prevalence by sites [%; (n/N)] | |||||||
|---|---|---|---|---|---|---|---|
Genes | Codons | Genotypes | LTV | FGM | KMT | FCV | p |
Pfcrt | |||||||
SNPs | 76 | K | 16.5 (33/200) | 27.8 (10/36) | 17.4 (20/115) | 29.4 (15/51) | 0.09 |
K/T | 10.5 (21/200) | 0.0 (0/36) | 0.0 (0/115) | 17.6 (9/51) | ND | ||
86 | N | 57.8 (144/249) | 51.2 (21/41) | 45.4 (49/108) | 62.2 (23/37) | 0.12 | |
N/Y | 10.4 (26/249) | 17.1 (7/41) | 17.6 (19/108) | 5.4 (2/37) | 0.10 | ||
184 | Y/F | 0.0 | 0.0 | 0.0 | 0.0 | ND | |
F | 73.8 (175/237) | 81.6 (31/38) | 83.2 (84/101) | 80.6 (25/31) | 0.24 | ||
1246 | D | 94.1 (255/271) | 100.0 (32/32) | 85.6 (95/111) | 87.3 (48/55) | ND | |
D/Y | 3.3 (9/271) | 0.0 (0/32) | 12.6 (14/111) | 9.1 (5/55) | ND | ||
pfmdr1 | |||||||
Haplotypes | 86/184/1246 | NFD | 46.6 (110/236) | 45.5 (15/33) | 35.0 (31/89) | 40.0 (10/25) | 0.28 |
NYD | 14.0 (33/236) | 9.1 (3/33) | 6.7 (6/89) | 16.0 (4/25) | ND | ||
YFD | 25.8 (61/236) | 42.4 (14/33) | 40.4 (36/89) | 32.0 (8/25) | 0.03 | ||
YYD | 8.5 (20/236) | 3.0 (1/33) | 4.5 (4/89) | 4.0 (1/25) | ND | ||
NFY | 1.3 (3/236) | 0.0 | 6.7 (6/89) | 0.0 | ND | ||
NYY | 0.0 | 0.0 | 4.5 (4/89) | 4.0 (1/25) | ND | ||
YYY | 1.7 (4/236) | 0.0 | 2.2 (2/89) | 0.0 | ND | ||
YFY | 2.1 (5/236) | 0.0 | 0.0 | 4.0 (1/25) | ND | ||